Canadian Provincial Trends in Antihypertensive Drug Prescriptions Between 1996 and 2006

Canadian Journal of Cardiology

Volumn 27, Issue 4, 2011, Pages 461-467

  Walker, Robin L ^a   Chen, Guanmin ^a   Campbell, Norman R C ^a,b   McAlister, Finlay A ^c   Quan, Hude ^b   Tu, Karen ^d   Khan, Nadia A ^e   Hemmelgarn, Brenda R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENAZEPRIL; BISOPROLOL; CAPTOPRIL; CHLORTALIDONE; CILAZAPRIL; ENALAPRIL; FELODIPINE; FOSINOPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LABETALOL; LISINOPRIL; METOLAZONE; METOPROLOL; NADOLOL; NIFEDIPINE; OXPRENOLOL; PERINDOPRIL; PINDOLOL; PROPRANOLOL; QUINAPRIL; RAMIPRIL; SOTALOL; TIMOLOL; TRANDOLAPRIL; UNINDEXED DRUG;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CANADA; COMBINATION CHEMOTHERAPY; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MONOTHERAPY; PRESCRIPTION;

ADULT; ANTIHYPERTENSIVE AGENTS; CANADA; HUMANS; HYPERTENSION; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS;

EID: 80052406008     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2010.12.071     Document Type: Article

References (18)

1. Vasan R.S., Beiser A., Seshadri S., et al. Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA 2002, 287:1003-1010.
2. Rodgers A., Vaughan P., Prentice T., Edejer T.T.-T., Evans D. The World Health Report 2002 2002, World Health Organization, Geneva, Switzerland.
3. Turnbull F., Neal B., Algert C., Chalmers J., Woodward M., MacMahon S. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-1535.
4. Collins R., Peto R., MacMahon S., et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990, 335:827-838.
5. Joffres M.R., Ghadirian P., Fodor J.G., Petrasovits A., Chockalingam A., Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997, 10:1097-1102.
6. Campbell N.R.C., Tu K., Brant R., Duong-Hua M., McAlister F.A. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension 2006, 47:22-28.
7. Leenen F.H., Dumais J., McInnis N.H., et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008, 178:1441-1449.
8. Tu K. Hypertension management by family physicians: is it time to pat ourselves on the back?. Can Fam Physician 2009, 55:684-687.
9. Campbell N.R., McAlister F.A., Brant R., et al. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian hypertension education program. J Hypertens 2003, 21:1591-1597.
10. Jackevicius C.A., Tu K., Filate W.A., Brien S.E., Tu J.V. Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001. Can J Cardiol 2003, 19:1359-1366.
11. Hemmelgarn B.R., Chen G., Walker R., et al. Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. Can J Cardiol 2008, 24:507-512.
12. Onysko J., Maxwell C., Eliasziw M., Zhang J., Johansen H., Campbell N. Large increases in hypertension diagnosis and treatment in Canada following a health care professional education program. Hypertension 2006, 48:853-860.
13. Grootendorst P. Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment. Can J Clin Pharmacol 2002, 9:79-99.
14. Laupacis A. Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?. CMAJ 2002, 166:44-47.
15. Gregoire J.P., MacNeil P., Skilton K., et al. Inter-provincial variation in government drug formularies. Can J Public Health 2001, 92:307-312.
16. Canadian Community Health Survey Statistics Canada, Web site, Accessed August 20, 2009. http://www40.statcan.ca/l01/cst01/health03b-eng.htm.
17. Mohan S., Chen G., Campbell N.R.C., Hemmelgarn B.R. Regional variations in not treating diagnosed hypertension in Canada. Can J Cardiol 2010, 26:409-413.
18. Kent H. BC's reference-based pricing stirs controversy. CMAJ 2000, 162:1190.